Pharma & Biotech

The biotechnology sector is renowned for its volatility, but the upcoming financial report from Valneva could unsettle even the most...

Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent waters as a significant governance conflict unfolds. The company's shares, already...

NuCana plc witnessed a significant sell-off on Thursday, with its shares plunging 7.92 percent to close at $3.49. This sharp...

The biotech sector has a new standout performer, yet BridgeBio Pharma's remarkable surge conceals a troubling divergence. As clinical trial...

Equillium shares posted significant gains in today's trading session following the release of encouraging quarterly figures and the announcement of...

The German biotech firm BioNTech finds itself navigating turbulent waters following a significant divestment by its longtime collaborator. In a...

In a surprising market development, Relmada Therapeutics witnessed its stock value drop by more than 3% during premarket trading. This...

The biotechnology sector is witnessing the emergence of a standout performer as Alnylam demonstrates remarkable momentum. The company is not...

The recent quarterly report from Protara Therapeutics presents investors with a curious market puzzle. Despite posting financial results that surpassed...

Shares of Aclaris Therapeutics are demonstrating significant upward momentum, propelled by a confluence of positive clinical developments and robust financial...